Single-molecule imaging of chromatin remodelers reveals role of ATPase in promoting fast kinetics of target search and dissociation from chromatin

  1. Jee Min Kim
  2. Pat Visanpattanasin
  3. Vivian Jou
  4. Sheng Liu
  5. Xiaona Tang
  6. Qinsi Zheng
  7. Kai Yu Li
  8. Jonathan Snedeker
  9. Luke D Lavis
  10. Timothee Lionnet
  11. Carl Wu  Is a corresponding author
  1. Johns Hopkins University, United States
  2. Janelia Research Campus, United States
  3. Janelia Research Campus, Howard Hughes Medical Institute, United States
  4. New York University, United States

Abstract

Conserved ATP-dependent chromatin remodelers establish and maintain genome-wide chromatin architectures of regulatory DNA during cellular lifespan, but the temporal interactions between remodelers and chromatin targets have been obscure. We performed live-cell single-molecule tracking for RSC, SWI/SNF, CHD1, ISW1, ISW2, and INO80 remodeling complexes in budding yeast and detected hyperkinetic behaviors for chromatin-bound molecules that frequently transition to the free state for all complexes. Chromatin-bound remodelers display notably higher diffusion than nucleosomal histones, and strikingly fast dissociation kinetics with 4-7 s mean residence times. These enhanced dynamics require ATP binding or hydrolysis by the catalytic ATPase, uncovering an additional function to its established role in nucleosome remodeling. Kinetic simulations show that multiple remodelers can repeatedly occupy the same promoter region on a timescale of minutes, implicating an unending ‘tug-of-war’ that controls a temporally shifting window of accessibility for the transcription initiation machinery.

Data availability

All custom scripts and imaging data files have been deposited in Mendeley Data and are publicly available via: https://data.mendeley.com/datasets/ydwcx9yhpp/2 (DOI: 10.17632/ydwcx9yhpp.2).

Article and author information

Author details

  1. Jee Min Kim

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Competing interests
    No competing interests declared.
  2. Pat Visanpattanasin

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9506-8360
  3. Vivian Jou

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Competing interests
    No competing interests declared.
  4. Sheng Liu

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Competing interests
    No competing interests declared.
  5. Xiaona Tang

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Competing interests
    No competing interests declared.
  6. Qinsi Zheng

    Howard Hughes Medical Institute, Janelia Research Campus, Ashburn, United States
    Competing interests
    Qinsi Zheng, L.D.L. and Q.Z. are listed as inventors on patents and patent applications whose value might be affected by publication. US Patent 9,933,417 and Patent Application 2021/0085805 describing azetidine-containing fluorophores and variant compositions (with inventors Q.Z., L.D.L., and T.L.) are assigned to HHMI..
  7. Kai Yu Li

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Competing interests
    No competing interests declared.
  8. Jonathan Snedeker

    Department of Biology, Johns Hopkins University, Baltimore, United States
    Competing interests
    No competing interests declared.
  9. Luke D Lavis

    Janelia Research Campus, Howard Hughes Medical Institute, Ashburn, United States
    Competing interests
    Luke D Lavis, L.D.L. and Q.Z. are listed as inventors on patents and patent applications whose value might be affected by publication. US Patent 9,933,417 and Patent Application 2021/0085805 describing azetidine-containing fluorophores and variant compositions (with inventors Q.Z., L.D.L., and T.L.) are assigned to HHMI..
  10. Timothee Lionnet

    Langone Medical Center, Institute of System Genetics, New York University, New York, United States
    Competing interests
    Timothee Lionnet, T.L. holds intellectual property rights related to Janelia Fluor dyes used in this publication. US Patent 9,933,417 and Patent Application 2021/0085805 describing azetidine-containing fluorophores and variant compositions (with inventors Q.Z., L.D.L., and T.L.) are assigned to HHMI..
  11. Carl Wu

    Department of Biology, Johns Hopkins University, Baltimore, United States
    For correspondence
    wuc@jhu.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0001-6933-5763

Funding

National Institutes of Health (GM132290)

  • Carl Wu

National Institutes of Health (GM127538)

  • Timothee Lionnet

Korean Foundation for Advanced Studies Fellowship

  • Jee Min Kim

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Copyright

© 2021, Kim et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 3,708
    views
  • 539
    downloads
  • 54
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Jee Min Kim
  2. Pat Visanpattanasin
  3. Vivian Jou
  4. Sheng Liu
  5. Xiaona Tang
  6. Qinsi Zheng
  7. Kai Yu Li
  8. Jonathan Snedeker
  9. Luke D Lavis
  10. Timothee Lionnet
  11. Carl Wu
(2021)
Single-molecule imaging of chromatin remodelers reveals role of ATPase in promoting fast kinetics of target search and dissociation from chromatin
eLife 10:e69387.
https://doi.org/10.7554/eLife.69387

Share this article

https://doi.org/10.7554/eLife.69387

Further reading

    1. Chromosomes and Gene Expression
    2. Microbiology and Infectious Disease
    Maruti Nandan Rai, Qing Lan ... Koon Ho Wong
    Research Article Updated

    Candida glabrata can thrive inside macrophages and tolerate high levels of azole antifungals. These innate abilities render infections by this human pathogen a clinical challenge. How C. glabrata reacts inside macrophages and what is the molecular basis of its drug tolerance are not well understood. Here, we mapped genome-wide RNA polymerase II (RNAPII) occupancy in C. glabrata to delineate its transcriptional responses during macrophage infection in high temporal resolution. RNAPII profiles revealed dynamic C. glabrata responses to macrophages with genes of specialized pathways activated chronologically at different times of infection. We identified an uncharacterized transcription factor (CgXbp1) important for the chronological macrophage response, survival in macrophages, and virulence. Genome-wide mapping of CgXbp1 direct targets further revealed its multi-faceted functions, regulating not only virulence-related genes but also genes associated with drug resistance. Finally, we showed that CgXbp1 indeed also affects fluconazole resistance. Overall, this work presents a powerful approach for examining host-pathogen interaction and uncovers a novel transcription factor important for C. glabrata’s survival in macrophages and drug tolerance.

    1. Chromosomes and Gene Expression
    2. Neuroscience
    Robyn D Moir, Emilio Merheb ... Ian M Willis
    Research Article

    Pathogenic variants in subunits of RNA polymerase (Pol) III cause a spectrum of Polr3-related neurodegenerative diseases including 4H leukodystrophy. Disease onset occurs from infancy to early adulthood and is associated with a variable range and severity of neurological and non-neurological features. The molecular basis of Polr3-related disease pathogenesis is unknown. We developed a postnatal whole-body mouse model expressing pathogenic Polr3a mutations to examine the molecular mechanisms by which reduced Pol III transcription results primarily in central nervous system phenotypes. Polr3a mutant mice exhibit behavioral deficits, cerebral pathology and exocrine pancreatic atrophy. Transcriptome and immunohistochemistry analyses of cerebra during disease progression show a reduction in most Pol III transcripts, induction of innate immune and integrated stress responses and cell-type-specific gene expression changes reflecting neuron and oligodendrocyte loss and microglial activation. Earlier in the disease when integrated stress and innate immune responses are minimally induced, mature tRNA sequencing revealed a global reduction in tRNA levels and an altered tRNA profile but no changes in other Pol III transcripts. Thus, changes in the size and/or composition of the tRNA pool have a causal role in disease initiation. Our findings reveal different tissue- and brain region-specific sensitivities to a defect in Pol III transcription.